Intelligent Supply Chain Planning and Advanced Manufacturing Equipment Technology for Modern Traditional Chinese Medicine Manufacturing

Shenwei Pharmaceutical Group Co., Ltd. is a large-scale comprehensive enterprise group established on December 30, 2003, with modern Chinese medicine as its main business. It is a listed company on the Hong Kong Main Board. The main business covers the breeding, planting, research and development of traditional Chinese medicine, traditional Chinese medicine preparations, formula granules, traditional Chinese medicine decoction pieces, health products, biopharmaceuticals, Shenwei Pharmacy Chain, Shenwei Traditional Chinese Medicine Hall, Internet Medical and other upstream, midstream, and downstream industrial chains, achieving full coverage of the traditional Chinese medicine industry from the field to the terminal. It is one of the large pharmaceutical enterprise groups with a complete layout of the pharmaceutical health industry.
At present, there are national recognized enterprise technology centers and postdoctoral research workstations, as well as national laboratories recognized by CNAS, national and local joint engineering laboratories, Hebei Province Traditional Chinese Medicine Formula Granule Technology Innovation Center, Hebei Province Key Laboratory for Classic and Modern Traditional Chinese Medicine Quality Process Control, Yunnan Province Traditional Chinese Medicine Formula Granule Engineering Research Center, and other innovation platforms.
Project introduction: The
pharmaceutical industry is an important industry related to the national economy and the people's livelihood. It is a key area of Made in China 2025 and strategic emerging industries, and an important guarantee for promoting the construction of a healthy China. Compared to Western medicine, traditional Chinese medicine has the characteristics and advantages of multiple targets, multiple pathways, natural origin, minimal side effects, definite therapeutic effects, and relatively low prices in treating diseases. It has increasingly attracted people's attention worldwide, and multiple products have become national strategic reserve drugs, playing an irreplaceable role in the prevention and control of large-scale major epidemics in China.
China has a huge demand for traditional Chinese medicine, but compared to the traditional Chinese medicine industry in China, the production process and equipment are outdated, quality standards are not perfect, and the quality stability and uniformity control of products are becoming increasingly prominent. It has been greatly impacted by European botanical medicine, Japanese and Korean Chinese herbal medicine. Therefore, building a modern digital and intelligent supply chain for traditional Chinese medicine that widely applies modern intelligent manufacturing equipment can effectively ensure stable product quality, improve production quality control standards and product standards for large varieties of traditional Chinese medicine, drive the overall level of China's traditional Chinese medicine industry to improve, and gain recognition from the international mainstream market for future innovative traditional Chinese medicine. This will further consolidate China's leading position in the development of traditional Chinese medicine in the world.
At present, promoting intelligent manufacturing and the development of traditional Chinese medicine is an important part of the national "14th Five Year Plan". Realizing the digitization and intelligence of the entire production process of traditional Chinese medicine will become a long-term development trend in the traditional Chinese medicine industry.
Intended countries: Germany and France. The
main problems to be solved through the project include: 
project characteristics: achieving automation, digitization, and intelligence in the traditional Chinese medicine supply chain.
Usage: 
intelligent supply technology indicators for traditional Chinese medicine manufacturing: 1. overall planning and process design of the intelligent supply chain; 2. Construction of a digital production line for traditional Chinese medicine extraction; 3. Construction of digital production lines for traditional Chinese medicine preparations; 4. Intelligent warehousing construction;
Technical maturity: from 2023 to 2027, it is proposed to invest 2 billion yuan, add 200 mu of construction land, build a new automatic flow production line for deep and fine processing of Chinese herbal pieces, a Chinese herbal medicine extraction workshop, a Chinese herbal medicine preparation workshop, and a Chinese herbal medicine intelligent storage project, transform the existing plant facilities, and comprehensively introduce advanced technologies such as industrial Internet, Internet of Things, Big data, artificial intelligence, cloud computing, etc, To achieve the requirements of green, standardized, and intelligent production of the entire industry chain of "traditional Chinese medicine processing extraction concentration refinement formulation inspection warehousing", and to construct innovative technology bottles and industrial application systems for intelligent production of traditional Chinese medicine.